Baxter (BAX) has been hiking its dividend regularly and by a lot. In May, the bioscience and medical device manufacturer raised its dividend by 9%, which came hard on the heels of a 34% increase at the end of 2012. The current dividend yields 3% vs. a five-year average of 2.8%.
Additionally, Baxter’s board approved a new share repurchase program for up to $2 billion in stock. That’s on top of the $450 million left from an older $2.5 billion share repurchase program.
As of this writing, Dan Burrows did not hold a position in any of the aforementioned securities.